Hyakumura Tomoko, Aregueta-Robles Ulises, Duan Wenlu, Villalobos Joel, Adams Wendy K, Poole-Warren Laura, Fallon James B
The Bionics Institute of Australia, East Melbourne, VIC, Australia.
Department of Medical Bionics, The University of Melbourne, Parkville, VIC, Australia.
Front Neurosci. 2021 Nov 5;15:761525. doi: 10.3389/fnins.2021.761525. eCollection 2021.
Active implantable neurological devices like deep brain stimulators have been used over the past few decades to treat movement disorders such as those in people with Parkinson's disease and more recently, in psychiatric conditions like obsessive compulsive disorder. Electrode-tissue interfaces that support safe and effective targeting of specific brain regions are critical to success of these devices. Development of directional electrodes that activate smaller volumes of brain tissue requires electrodes to operate safely with higher charge densities. Coatings such as conductive hydrogels (CHs) provide lower impedances and higher charge injection limits (CILs) than standard platinum electrodes and support safer application of smaller electrode sizes. The aim of this study was to examine the chronic performance of a new low swelling CH coating that supports higher safe charge densities than traditional platinum electrodes. A range of hydrogel blends were engineered and their swelling and electrical performance compared. Electrochemical performance and stability of high and low swelling formulations were compared during insertion into a model brain and the formulation with lower swelling characteristics was chosen for the study. CH-coated or uncoated Pt electrode arrays were implanted into the brains of 14 rats, and their electrochemical performance was tested weekly for 8 weeks. Tissue response and neural survival was assessed histologically following electrode array removal. CH coating resulted in significantly lower voltage transient impedance, higher CIL, lower electrochemical impedance spectroscopy, and higher charge storage capacity compared to uncoated Pt electrodes , and this advantage was maintained over the 8-week implantation. There was no significant difference in evoked potential thresholds, signal-to-noise ratio, tissue response or neural survival between CH-coated and uncoated Pt groups. The significant electrochemical advantage and stability of CH coating in the brain supports the suitability of this coating technology for future development of smaller, higher fidelity electrode arrays with higher charge density requirement.
在过去几十年里,诸如深部脑刺激器等有源植入式神经装置已被用于治疗运动障碍,如帕金森病患者的运动障碍,最近也用于治疗强迫症等精神疾病。支持安全有效地靶向特定脑区的电极 - 组织界面对于这些装置的成功至关重要。开发能够激活更小脑组织体积的定向电极需要电极在更高的电荷密度下安全运行。与标准铂电极相比,诸如导电水凝胶(CHs)之类的涂层具有更低的阻抗和更高的电荷注入极限(CILs),并支持更安全地应用更小尺寸的电极。本研究的目的是检验一种新型低膨胀CH涂层的长期性能,该涂层比传统铂电极支持更高的安全电荷密度。设计了一系列水凝胶混合物,并比较了它们的膨胀和电性能。在插入模型脑的过程中比较了高膨胀和低膨胀配方的电化学性能和稳定性,并选择具有较低膨胀特性的配方进行研究。将涂有CH或未涂CH的铂电极阵列植入14只大鼠的脑中,并每周测试其电化学性能,持续8周。在移除电极阵列后,通过组织学评估组织反应和神经存活情况。与未涂CH的铂电极相比,CH涂层导致电压瞬态阻抗显著降低、CIL更高、电化学阻抗谱更低以及电荷存储容量更高,并且这种优势在8周的植入过程中得以保持。涂有CH和未涂CH的铂电极组在诱发电位阈值、信噪比、组织反应或神经存活方面没有显著差异。CH涂层在脑中具有显著的电化学优势和稳定性,这支持了这种涂层技术适用于未来开发具有更高电荷密度要求的更小、更高保真度的电极阵列。